These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8255285)

  • 21. Chimeric adenovirus type 5/35 vector encoding SIV gag and HIV env genes affords protective immunity against the simian/human immunodeficiency virus in monkeys.
    Someya K; Xin KQ; Ami Y; Izumi Y; Mizuguchi H; Ohta S; Yamamoto N; Honda M; Okuda K
    Virology; 2007 Oct; 367(2):390-7. PubMed ID: 17628628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AIDS vaccines show promise in primates.
    Clin Infect Dis; 2001 Oct; 33(7):i-ii. PubMed ID: 11592258
    [No Abstract]   [Full Text] [Related]  

  • 23. HIV vaccine design: insights from live attenuated SIV vaccines.
    Koff WC; Johnson PR; Watkins DI; Burton DR; Lifson JD; Hasenkrug KJ; McDermott AB; Schultz A; Zamb TJ; Boyle R; Desrosiers RC
    Nat Immunol; 2006 Jan; 7(1):19-23. PubMed ID: 16357854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Late appearance of human immunodeficiency virus infection among Danish intravenous drug addicts].
    Pedersen C; Sindrup JH; Worm AM; Krogsgaard K
    Ugeskr Laeger; 1987 Oct; 149(44):2963-4. PubMed ID: 3433483
    [No Abstract]   [Full Text] [Related]  

  • 25. Vaccines. Monkey puzzles.
    Cohen J
    Science; 2002 Jun; 296(5577):2325-6. PubMed ID: 12089425
    [No Abstract]   [Full Text] [Related]  

  • 26. Vaccination against SIV infection and disease.
    Gardner MB
    AIDS Res Hum Retroviruses; 1990 Jul; 6(7):835-46. PubMed ID: 2167709
    [No Abstract]   [Full Text] [Related]  

  • 27. Oral administration of recombinant adeno-associated virus elicits human immunodeficiency virus-specific immune responses.
    Xin KQ; Ooki T; Mizukami H; Hamajima K; Okudela K; Hashimoto K; Kojima Y; Jounai N; Kumamoto Y; Sasaki S; Klinman D; Ozawa K; Okuda K
    Hum Gene Ther; 2002 Sep; 13(13):1571-81. PubMed ID: 12228012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Developments in preclinical AIDS vaccine efficacy models.
    Bogers WM; Cheng-Mayer C; Montelaro RC
    AIDS; 2000; 14 Suppl 3():S141-51. PubMed ID: 11086857
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunogenicity and protective efficacy of oligomeric human immunodeficiency virus type 1 gp140.
    Earl PL; Sugiura W; Montefiori DC; Broder CC; Lee SA; Wild C; Lifson J; Moss B
    J Virol; 2001 Jan; 75(2):645-53. PubMed ID: 11134278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetics: the quiet revolution in science and medicine. Implications for research on child health issues, education of health professionals, and the new preventive and curative medicine.
    Fulginiti VA
    Am J Dis Child; 1993 Nov; 147(11):1139-41. PubMed ID: 8237906
    [No Abstract]   [Full Text] [Related]  

  • 31. [The immunological manifestations and cytological characteristics of infection caused by the simian immunodeficiency virus (SIV) in rhesus monkeys].
    Persidskiĭ IuV; Shcherbinskaia AM; Barshteĭn IuA; Antonenko SV; Marichev IL
    Tsitol Genet; 1993; 27(6):97-104. PubMed ID: 8066812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genomic and biological alteration of a human immunodeficiency virus type 1 (HIV-1)-simian immunodeficiency virus strain mac chimera, with HIV-1 Env, recovered from a long-term carrier monkey.
    Igarashi T; Kuwata T; Takehisa J; Ibuki K; Shibata R; Mukai R; Komatsu T; Adachi A; Ido E; Hayami M
    J Gen Virol; 1996 Aug; 77 ( Pt 8)():1649-58. PubMed ID: 8760411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Update on vaccine development in AIDS and cancer.
    MacDougall DS
    J Int Assoc Physicians AIDS Care; 1995 Apr; 1(3):18-24. PubMed ID: 11362485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immunization against HIV. Problems in developing a vaccine].
    Uhl D
    Med Monatsschr Pharm; 1988 Nov; 11(11):376-8. PubMed ID: 3059163
    [No Abstract]   [Full Text] [Related]  

  • 35. HIV-1 vaccines based on replication-competent Tiantan vaccinia protected Chinese rhesus macaques from simian HIV infection.
    Liu Q; Li Y; Luo Z; Yang G; Liu Y; Liu Y; Sun M; Dai J; Li Q; Qin C; Shao Y
    AIDS; 2015 Mar; 29(6):649-58. PubMed ID: 25849828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro characterization of a simian immunodeficiency virus-human immunodeficiency virus (HIV) chimera expressing HIV type 1 reverse transcriptase to study antiviral resistance in pigtail macaques.
    Ambrose Z; Boltz V; Palmer S; Coffin JM; Hughes SH; Kewalramani VN
    J Virol; 2004 Dec; 78(24):13553-61. PubMed ID: 15564466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cross-reactivity with SIVmac in east African HIV-1-positive sera: evidence against double infection with HIV-1 and a SIVmac/HIV-2-like virus.
    Blomberg J; Klasse PJ; Pehrson C
    Intervirology; 1990; 31(5):276-84. PubMed ID: 1703133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overview of the landscape of HIV prevention.
    Haase AT
    Am J Reprod Immunol; 2014 Jun; 71(6):490-4. PubMed ID: 24702688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simian immunodeficiency viruses.
    Desrosiers RC
    Annu Rev Microbiol; 1988; 42():607-25. PubMed ID: 2849374
    [No Abstract]   [Full Text] [Related]  

  • 40. Protection of monkeys vaccinated with vpr- and/or nef-defective simian immunodeficiency virus strain mac/human immunodeficiency virus type 1 chimeric viruses: a potential candidate live-attenuated human AIDS vaccine.
    Igarashi T; Ami Y; Yamamoto H; Shibata R; Kuwata T; Mukai R; Shinohara K; Komatsu T; Adachi A; Hayami M
    J Gen Virol; 1997 May; 78 ( Pt 5)():985-9. PubMed ID: 9152414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.